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Abstract
Background: Hypoxia Inducible Factors (HIF1a and HIF2a) are commonly stabilized and play key roles related to cell growth
and metabolic programming in clear cell renal cell carcinoma. The relationship of these factors to discretely alter cell
metabolic activities has largely been described in cancer cells, or in hypoxic conditions, where other confounding factors
undoubtedly compete. These transcription factors and their specific roles in promoting cancer metabolic phenotypes from
the earliest stages are poorly understood in pre-malignant cells.
Methods: We undertook an analysis of SV40-transformed primary kidney epithelial cells derived from newborn mice
genetically engineered to express a stabilized HIF1a or HIF2a transgene. We examined the metabolic profile in relation to
each gene.
Results: Although the cells proliferated similarly, the metabolic profile of each genotype of cell was markedly different and
correlated with altered gene expression of factors influencing components of metabolic signaling. HIF1a promoted high
levels of glycolysis as well as increased oxidative phosphorylation in complete media, but oxidative phosphorylation was
suppressed when supplied with single carbon source media. HIF2a, in contrast, supported oxidative phosphorylation in
complete media or single glucose carbon source, but these cells were not responsive to glutamine nutrient sources. This
finding correlates to HIF2a-specific induction of Glul, effectively reducing glutamine utilization by limiting the glutamate
pool, and knockdown of Glul allows these cells to perform oxidative phosphorylation in glutamine media.
Conclusion: HIF1a and HIF2a support highly divergent patterns of kidney epithelial cell metabolic phenotype. Expression of
these factors ultimately alters the nutrient resource utilization and energy generation strategy in the setting of complete or
limiting nutrients.
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Introduction
Clear cell renal cell carcinoma (ccRCC) is the most common
subtype of renal cell carcinoma (RCC) making up over 70% of
RCC cases. ccRCC is considered to arise from cells of the renal
tubule epithelium, and the majority of ccRCC cases contain
inactivation of the tumor suppressor gene, von Hippel-Lindau
(VHL), either by mutation or deletion [1,2]. VHL protein (pVHL)
acts as a tumor suppressor through its role as the substrate
recognition protein in the E3 ubiquitin ligase complex, VBC [3].
pVHL is involved in numerous processes [4–6], but one of the
most widely characterized is the regulation of a family of
transcription factors, hypoxia inducible factors (HIFs), in an
oxygen dependent manner [7]. Under normal oxygen conditions,
prolyl hydroxylases (PHD1, 2, 3) add a hydroxyl group to proline
residues on HIF1a (alpha) and HIF2a. These hydroxylated
residues are recognized by the VBC complex, and both HIF
factors are polyubiquitylated and rapidly degraded by the
proteasome [8]. When pVHL is inactivated by mutation or
deletion, HIFa subunits escape VBC mediated regulation and are
stably present in the cytoplasm regardless of the oxygen state of the
cell. They heterodimerize with the cognate partner, aryl hydro-
carbon receptor nuclear transporter (ARNT), also known as HIFb
(beta). HIF a/b heterodimers translocate to the nucleus where
they regulate transcription of target genes. Importantly, HIFa
isoforms, HIF1a and HIF2a, can be distinctly expressed in both
normal and cancer cells where they may exert specific effects on
cell phenotype and metabolism that are not well understood.
These effects are particularly uncertain in the case of HIF2a.
PLOS ONE | www.plosone.org 1 May 2014 | Volume 9 | Issue 5 | e98705Hypoxia inducible factors HIF1 and HIF2 (referring to each a/
b heterodimeric complex) are predicted to play roles in
differentiation [9,10], vasculogenesis [10,11], cell growth
[9,12,13], and metabolic function [14]. Aberrant expression or
dysregulation of these factors can initiate transcriptional activation
programs to ultimately create a more favorable environment for
tumorigenesis. Efforts to clarify transcriptional targets have shown
differential roles for HIF1 and HIF2 in gene target regulation
[14,15]. HIF1 is generally described as regulating genes important
for metabolic, and in particular glycolytic, function [16]; while
HIF2 has more often been observed to regulate cell growth and
angiogenic functions, with few roles being attributed to cellular
metabolism. However, the majority of studies designed to tease
apart differential activities of HIF factors have revealed a high
degree of tissue dependence on functional outputs [17].
Differential expression of HIF1 and HIF2 in ccRCC has been
observed, with human tumors either expressing HIF1 and HIF2 or
only HIF2, although the functional effect of the differing
expression profiles on metabolic regulation are not fully under-
stood [12]. Recent evidence suggests that the HIF1a locus is
selectively lost in ccRCC tumors during progression to higher
stages [18]. Carcinoma is increasingly being characterized as a
metabolic disease based on the cancer cells’ dependence on
various necessary nutrients from healthy surrounding cells [19,20],
or the dysregulation of metabolic machinery to ensure continued
growth [21]. In particular, ccRCC tumors display unique
metabolic features that define the cancer in genomic investigations
[22,23].
Little is known about the individual contributions of HIF1 and
HIF2 in metabolic processes. Recently, HIF1, more than HIF2, in
RCC cells has been found to promote a glutamine-dependent
reductive carboxylation metabolic phenotype [24]. We sought to
identify the metabolic effects of stable expression of HIF1 or HIF2
in renal-derived cells to reveal the differences and similarities in
contributions to metabolic programming and nutrient utilization
by these transcription factors.
Results and Discussion
Neonatal Epithelial Kidney Culture System Provides an
In vitro Model to Study Genetically Engineered
Expression of HIF1 and HIF2
To focus on the differences in cellular function based on
expression of HIFs independent of pVHL regulation, we employed
a previously described transgenic mouse model of constitutive HIF
dysregulation [25]. The conditional mouse model system contains
a hemagglutinin (HA) tagged HIF1a subunit with a double proline
to alanine substitution (dPA) at amino acid residues 402 and 564,
here referred to as HIF1dPA; a separate mouse contains the HA-
tagged HIF2a subunit with residues 405 and 531 containing
proline to alanine substitutions, here referred to as HIF2dPA. Site-
specific mutagenesis at these proline residues prevents hydroxyl-
ation by PHDs, thereby preventing polyubiquitination by the VBC
complex and proteosomal degradation. Expression of these alleles
is under control of the constitutively active Rosa26 promoter.
Following recombination of loxP-stop-loxP (LSL) sites, HIFdPAs
are stably expressed (Figure 1A).
Primary neonatal epithelial kidney (NEK) cell cultures [26,27]
(Figure 1B) were isolated using neonatal (0–3 days post birth)
murine kidneys. Nephrogenesis, the development and growth of
kidneys, continues up to postnatal day 3 and prior to this point the
kidneys have not fully developed or terminally differentiated [28].
There remains an immature cell population that provides a
platform for the exclusion of fibroblast cells and the promotion of
epithelial cell growth by culturing the cells in serum-free media
supplemented with epidermal growth factor (EGF).
Recombination of the R26-LSL alleles to activate expression of
the HIFdPA was done by using the knock-in, 4-hydroxy tamoxifen
(4-OHT) inducible ubiquitin C (UBC) Cre recombinase estrogen
receptor 2 (Cre-ER
T2) [29], allowing for complete recombination
in all cell types (Figures 1C and 1D). Increased gene expression for
the knock-in human HIF1a in HIF1dPA+ cells and HIF2a in
HIF2dPA+ cells were confirmed by quantitative real time PCR
(qRT-PCR) (Figures 1E and 1F). Confirmation of stable protein
expression of HIF1a is demonstrated by immunoblot in
HIF1dPA+ nuclear extracts (Figure 1G), and HIF2a in HIF2dPA+
cells by immunocytochemistry of cytospin preparations following
recombination (Figure 1H). While these cells retain endogenous
levels of HIF1a and HIF2a, they are normally expressed at low
levels. Our data show through several independent techniques that
this approach provides a basis for examining the individual effects
of stably expressed HIF1a or HIF2a, in the form of a stable
primary cell line derived from the murine kidney.
Stable HIF Expressing Cells Differentially Activate
Metabolic Target Genes
HIF1 and HIF2 are known to regulate several common
transcriptional targets, but independently are also capable of
transcriptionally regulating specific target genes [14]. To assess the
transcriptional function of the cell lines, qRT-PCR was performed
for canonical HIF targets, egl nine homolog 3, (Egln3) [30] and
vascular endothelial growth factor (Vegfa) [31]. Murine embryonic
stem (ES) cells expressing a construct with WT Vhl [32] that
exhibit maximal HIF regulation and Vhl null ES cells, where both
HIFs are endogenously stabilized, were employed as controls. As
expected, ES Vhl null cells had significantly elevated mRNA levels
over Vhl WT cells for both HIF targets. A significant elevation in
transcript levels of Egln3 by both HIF1dPA+ and HIF2dPA+ cells
was also observed. HIF1dPA+ cells only showed a slight increase
in Vegfa mRNA levels, but a significant increase was observed in
HIF2dPA+ cells (Figure 2A), consistent with previous reports
suggesting that Vegfa responds preferentially to HIF2 in mouse
models [33].
HIF1 has been regarded as a metabolic regulator by its known
transcriptional regulation of various metabolic targets including
the glucose transporter (Glut1); phosphofructokinase (Pfk1); lactate
dehydrogenase (Ldha1); and pyruvate dehydrogenase kinase (Pdk1),
which inhibits pyruvate dehydrogenase and the conversion of
pyruvate into acetyl CoA, thereby blocking carbon entry into the
tricarboxylic acid (TCA) cycle from glycolysis. Vhl null ES cells
display a significant increase over ES Vhl WT cells in Ldha1 and
Pfk1 mRNA levels by qRT-PCR. HIF1dPA+ cells also showed
significant increases in Ldha1, Pfk1, and Pdk1 mRNA levels over
the unrecombined partner cell line, HIF1dPA. HIF2dPA+ cells
did not show similar increases, and in fact showed a modest
reduction in transcript levels of the same targets compared to
HIF2dPA control cells (Figure 2B). All results were confirmed in at
least two independently derived NEK cell lines. This verified that
in our cell system, HIF1 is capable of regulating expression of
glycolytic enzymes at the transcript level.
To understand the transcriptional role HIF1dPA+ and
HIF2dPA+ cells might play in other metabolic processes, we
analyzed mRNA levels of several key enzymes regulating
metabolic activity (Figure 2C). We compared pyruvate carboxylase
(Pcx), which metabolizes pyruvate to oxaloacetate for anapleurotic
support of the TCA cycle. Additionally, we analyzed enzymes that
catabolize glutamate into glutamine (glutamine synthetase, Glul)
and glutamine into glutamate (glutaminase, Gls) for entry into the
HIF1 and HIF2 Effects on Metabolic Programs
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higher mRNA levels of Pcx, supporting anaplerosis, a reaction to
replenishing TCA cycle intermediates. HIF2dPA+ cells exhibited
an increased expression of Glul mRNA expression, an enzyme
driving the conversion of glutamate into glutamine, along with
decreased levels of Gls, indicating that glutamine sources may be
blocked from being effectively utilized in HIF2dPA+ cells.
Transcriptional regulation of these enzymes details a potential
role for HIF isoform expression in exerting influence in several key
metabolic transitions affecting nutrient utilization, TCA cycle
enzymes, as well as glycolysis. Examination of the equivalent
human metabolic enzyme gene sequences (Table 1) revealed at
least one putative hypoxia response element (HRE) upstream of
each transcriptional start site (TSS). Previous groups have shown
that some HIF target genes are known to contain functional HRE
binding sites several thousand base pairs upstream [34]. The
putative HRE binding sites in these genes still require individual
confirmation of direct binding to HIFs and functional validation as
transcriptional elements.
Glycolytic Function Differs According to Stable HIF
Expression
To explore the individual contribution of HIF1 and HIF2 to
metabolic activity in kidney epithelia, we employed the Seahorse
(XF) system to measure real-time extracellular metabolic flux and
oxidative phosphorylation based on proton excretion and oxygen
consumption, respectively [35]. HIF1 is well known to play a role
in driving glucose uptake into cancer cell lines and enhancing
glycolytic pathway activity [16,36], but the effect of isolated HIF2
expression on glycolysis is not well known, or is predicted to be
inconsequential. Primary NEK cells were cultured in complete
media and examined for glycolytic activity via the extracellular
acidification rate (ECAR) at basal levels and following the addition
of a glycolytic inhibitor, 2-deoxy-d-glucose (2-DG). HIF1dPA+
cells displayed significantly increased basal levels of ECAR (red)
compared to the control cell line, HIF1dPA (Figure 3A), as
predicted. HIF2dPA+ cells (blue), in contrast, displayed a
moderate reduction in basal levels of ECAR compared to
unrecombined cells (Figure 3B), suggesting that HIF2 expression
has a minor or potentially negative impact on production of lactic
Figure 1. Conditional stable expression of Hypoxia Inducible Factor in a murine derived primary cell culture system. (A) The
previously described transgenic mouse model [25] contains a HA-tagged human HIF1 or HIF2 insertion with double proline to alanine (dPA)
substitutions in the endogenous Rosa 26 locus with inducible loxP-stop-loxP sites. These mice were crossed with a mouse containing a tamoxifen-
inducible cre estrogen receptor ligand binding domain under control of a human ubiquitin C promoter [29]. Upon recombination, stable expression
of HIF1dPA and HIF2dPA is induced. Recombination is denoted as ‘‘dPA+’’ throughout the paper. (B) Primary neonatal epithelial kidney cells were
derived using both kidneys from a mouse 0–3 days post birth. The tissue was dissociated in collagenase IV and cultured in serum free (SF) media
supplemented with EGF. NEK cells were recombined using 4-hydroxy tamoxifen (4-OHT). (C) Recombination and loss of the Rosa26-Lox-Stop-Lox
alleles was confirmed in two newly isolated and recombined NEK HIF1dPA cells and (D) HIF2dPA cells by PCR primers specific to the R26LSL allele
followed by gel electrophoresis. (E) qRT-PCR for the human HIF1a transcript was significantly increased in HIF1dPA+ cells. (F) Similarly, gene
expression levels for the human HIF2a transcript was increased in HIF2dPA+ cells. (G) Immunoblot of nuclear extracts showed an increase in HIF1a
expression following 4-OHT treatment and quantification of immunoblot for HIF1 protein expression displayed increased expression following
recombination. Expression was normalized to an internal Lamin B control. (H) Immunocytochemistry for HIF2 protein expression in HIF2dPA+ cells
compared to unrecombined HIF2dPA cells was used to quantify levels of staining across several areas. Corrected Total Cell Staining indicated
significantly higher HIF2 protein levels in HIF2dPA+ cells. Bars indicate average with the SEM. **p#0.01, ‘p#0.001.
doi:10.1371/journal.pone.0098705.g001
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quantitative real time PCR. Fold change was calculated compared to the paired unrecombined cell line. (A) Gene expression of known joint targets
Egln3 and Vegfa. Vhl WT murine ES cells (endogenous HIFs lowly expressed) and Vhl null murine ES cells (endogenous HIFs highly expressed) show
the increased expression of these targets when both HIF1 and HIF2 are expressed. Significant increase of Egln3 expression in HIF1dPA+ and HIF2dPA+
cells, slight increase of Vegfa mRNA expression by HIF1dPA+, but significant increase of Vegfa by HIF2dPA+.( B) Expression of canonical HIF1
metabolic gene targets Lactate dehydrogenase (Ldha1), Pyruvate dehydrogenase kinase (Pdk1), and Phosphofructokinase (Pfk1). HIF1dPA+ cells have
statistically significant increase in expression of Ldha1, Pdk1 and Pfk1; HIF2dPA+ cells have decreased expression of the metabolic targets. (C)T o
assess the effect of HIF expression on metabolic gene expression, we analyzed gene expression by qRT-PCR of metabolic enzymes regulating entry
into and progression of the TCA cycle; fold change of 4-OHT treated cells to paired unrecombined NEK cell line is shown. Both HIF1dPA+ and
HIF2dPA+ cells had increased levels of Pyruvate carboxylase (Pcx) transcripts. HIF2dPA+ expressing cells showed increased levels of Glutamine
synthetase (Glul) and decreased Glutaminase (Gls). Bars indicate average with the SEM. *p#0.05, **p#0.01, (ns) not significant.
doi:10.1371/journal.pone.0098705.g002
Table 1. Putative Hypoxia Response Element binding sites of metabolic regulatory enzymes.
Gene HRE sequence Distance from TSS (bp)
Pyruvate carboxylase GCGTG .. 22769, 22089, 21954, 2747
ACGTG .2 7188, 25738
Glutamine synthetase GCGTG 23022, 22770, 22442, 21355
Glutaminase GCGTG 2506
doi:10.1371/journal.pone.0098705.t001
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confirming the measured acid production is derived primarily
from glucose metabolism.
To verify that the difference in glucose utilization via glycolysis
was not specific to one cell line or technique, we cultured an
independent set of cell lines, human embryonic kidney (HEK 293)
cells, induced for stable expression of either HIF1dPA+ or
HIF2dPA+ with a radiolabeled glucose substrate to measure the
amount of glucose metabolized and converted to radioactive water
by the glycolytic enzyme enolase. HEK 293 HIF1dPA+ cells
displayed significantly higher levels of glycolytic flux compared to
HEK293 HIF2dPA+ cells (Figure 3C), confirming the preferential
promotion of glycolytic function by HIF1 expressing cells.
Both HIF Factors Contribute to Oxidative
Phosphorylation in Complete Nutrient Environments
To assess whether HIF1 or HIF2 expression differentially
influences oxygen consumption, as has been previously predicted
[16,37,38], we measured oxygen consumption rate (OCR) by XF
assay. Somewhat surprisingly, in complete media, both HIF1dPA+
(Figure 3D) and HIF2dPA+ cells (Figure 3E) demonstrated
increased levels of basal oxidative phosphorylation (OxPhos) over
the unrecombined paired cell line (black). Treatment with an
OxPhos inhibitor, rotenone (Rot), which prevents complex 1
mitochondrial electron transfer thereby inhibiting the electron
transport chain [39], resulted in reduced oxygen consumption,
confirming the measured oxygen consumption is derived from
oxidative phosphorylation activity. Thus, NEK cells stably
expressing either HIF1 or HIF2 are capable of effecting increased
mitochondrial oxidative phosphorylation activity. Previous obser-
vations of hypoxia-driven Pdk1 expression had suggested that
HIF1 transcriptional activation of Pdk1 effectively blocked OxPhos
[38]. Our results suggest that OxPhos can be induced by HIF1
expression, despite the increased levels of Pdk1. The fold increase
in OxPhos in HIF1dPA+ cells compared to control, however, is
less than half that of HIF2dPA+ cells, suggesting an effect of partial
modulation or alternative pathways to TCA cycle activation
(Figure 3F).
Metabolic Pathway Preference Related to Carbohydrate
Substrate Availability
Cancer cells are capable of using various carbon sources to
support cellular functions, with glucose and glutamine providing
the majority of carbon nutrients [40–42]. To test nutrient
Figure 3. Metabolic function of differentially expressed HIF1 and HIF2. (A) Glycolytic function of NEK HIFdPA cells was quantified by
measuring real time proton excretion, extracellular acidification rate (ECAR), using the Seahorse system. HIF1dPA+ cells incubated in complete media
showed increased basal levels of glycolysis compared to HIF1dPA cells. Following treatment with a glycolytic inhibitor, 10 mM 2-deoxy-d-glucose (2-
DG), levels are decreased, but a significant difference remains. (B) Basal and post treatment levels of glycolytic activity in HIF2dPA and HIF2dPA+ cells
show no significant difference. (C) Glycolytic flux was measured in a separate cell line, human embryonic kidney cells (HEK 293) stably expressing
either HIF1dPA or HIF2dPA. HEK HIF1dPA+ cells showed significantly increased levels of glycolytic flux. Results show the average of two independent
runs. (D) Real time oxygen consumption rate (OCR) measurement in HIFdPA cells using the Seahorse system. HIF1dPA+ and (E) HIF2dPA+ cells have
significantly higher levels of basal OCR over the paired unrecombined cell line. Following treatment with 750nM rotenone, an oxidative
phosphorylation (OxPhos) inhibitor, OCR levels are greatly reduced. (F) Fold change in basal OCR levels show a significantly greater fold change in
HIF2dPA+ over HIF2dPA, compared to the paired HIF1dPA+/HIF1dPA cells. Graphs indicate average with the SEM. **p#0.01, ‘p#0.001, (ns) not
significant.
doi:10.1371/journal.pone.0098705.g003
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capabilities of NEK cells in the presence of media with only one
major carbon source at a time. The cells were assayed in media
with only glucose or L-glutamine as the main carbon source.
HIF1dPA+ cells showed a significant decrease in oxygen
consumption rate with glucose supplementation alone
(Figure 4A), with relatively stable OxPhos when glutamine was
the limiting carbon compared to control HIF1dPA cells
(Figure 4B). This finding is consistent with prior studies suggesting
a substantial shift toward aerobic glycolysis as the major metabolic
feature of HIF1 expressing cells, and indicates that glycolysis may
be the preferred method of energy production when nutrient
carbons are limited, particularly to glucose. However, in
conditions of unlimited nutrient resources, these cells are able to
utilize a variety of metabolic processes, including OxPhos.
In contrast, HIF2dPA+ cells demonstrated slightly increased
OCR levels over HIF2dPA control cells following the uptake of
glucose alone (Figure 4C), but OCR levels were significantly
suppressed in the presence of glutamine as a sole carbon source
(Figure 4D). These results suggest that HIF2 expressing cells may
utilize glucose as the preferred nutrient supporting mitochondrial
OxPhos, but that glutamine as a sole carbon source is insufficient
to support this process.
Selective Carbon Metabolism is Influenced by HIF1-
regulated Enzymes
The regulatory role of HIF1 on glycolysis is dependent on the
initial uptake of glucose and increased expression of key enzymes
of glycolysis. Secondarily, HIF1-dependent increases in Pdk1
further promote lactic acid production by shuttling glycolytic
substrates into lactate production. This has been suggested as a
feature promoting survival in hypoxic settings [37]. The increased
expression of Pdk1, primarily when induced in a hypoxic setting,
has been shown to result in decreased oxygen consumption [38].
Because we had observed a HIF1-dependent increase in OxPhos
in complete media, we wanted to assess how the levels of glycolytic
acid production and oxygen consumption were influenced by Pdk1
expression in this model system. We transfected HIF1dPA+ cells
with a pool of short hairpin (sh) RNAs specific to Pdk1 and
confirmed knockdown efficiency at about 90% by qRT-PCR after
24 hours (Figure 5A). HIF1dPA+ shPdk1 cells were then assayed
for ECAR and OCR levels following the addition of glucose. Pdk1
knockdown cells showed a decreased media acidification response
following glucose addition compared to HIF1dPA+ cells, which
express the induced level of Pdk1. The difference is lost after 2-DG
treatment confirming the effect is directly glucose dependent
(Figure 5B). This result suggests that HIF1-induced increase in
Pdk1 contributes to the effective glycolytic production of lactic
acid, likely via a component of diverting pyruvate away from the
TCA cycle and promoting its conversion to lactic acid instead.
Figure 4. Differences in carbon source consumption and regulation of metabolic enzymes by differential HIF expression. Oxygen
consumption rate (OCR) measurements before and after 750 nM Rotenone treatment of HIFdPA cells incubated in media supplemented with
individual carbon sources. (A) HIF1dPA+ cells in 10 mM Glucose showed a significant decrease in OCR levels. (B) HIF1dPA+ cells displayed no
difference in OCR with 2 mM L-glutamine. (C) HIF2dPA+ cells had no significant difference in OCR under glucose-supplemented conditions, (D) but
significantly reduced OCR under L-glutamine-supplemented media. Lines indicate average with the SEM. **p#0.01,
‘p#0.001, (ns) not significant.
doi:10.1371/journal.pone.0098705.g004
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oxygen consumption following glucose addition in Pdk1-deficient
cells (Figure 5C). This finding suggests that the reduced levels of
Pdk1 would allow for more pyruvate to follow through to the TCA
cycle and electron transport chain, resulting in a modest
contribution to increased oxidative phosphorylation. Additionally,
this finding and the reduced OxPhos observed in HIF1 expressing
cells fed glucose alone, leaves open the possibility that alternative
carbon sources may be contributing to the utilization of OxPhos
by these cells.
Glutamine Utilization by HIF2 is Dependent on Cellular
Retention of Glutamate
The uptake of glutamine in cells can be regulated by several
enzymes. As we previously described, HIF2dPA+ cells were less
efficient at utilizing glutamine carbon source for OxPhos, and
these cells displayed increased levels of Glul transcript, the enzyme
required for glutamate to glutamine conversion. Increased
expression of this enzyme would be predicted to reduce the
available glutamate as an alternative substrate in the TCA cycle.
We used a pool of four small interfering (si) RNAs to knockdown
Glul in HIF2dPA+ cells. We confirmed knockdown (Figure 6A) by
qRT-PCR compared to HIF2dPA+ cells. siGlul cells cultured in
L-glutamine now demonstrated increased OxPhos levels
(Figure 6B) compared to HIF2dPA+ cells, suggesting that this
enzyme was creating a rate-limiting step in the utilization of
glutamine for energy production. The OCR signal was quenched
by inhibitors of electron transport chain complex I (Antimycin A
and Rotenone), confirming that the signal reflected oxidative
phosphorylation. Thus, while HIF2 cells are able to drive oxidative
phosphorylation in the presence of complete media, and can
maintain OxPhos energy production at wild type levels with
glucose as a sole carbon source, their ability to metabolize
glutamine is limited by the upregulation of Glul. Further, we
observed a significant decrease in Gls, the enzyme that converts
glutamine to glutamate, in the HIF2 expressing cells, which may
further limit the utilization of glutamine as a resource to replenish
TCA cycle substrate levels.
Figure 5. HIF1 regulation of glucose utilization dependent on
Pdk1 expression. (A) qRT-PCR for the targeted transcript confirmed
knockdown of Pdk1 in HIF1dPA+ cells was ,90% by shRNA. (B)
HIF1dPA+ cells expressing shPdk1 showed decreased levels of ECAR
following administration of 10 mM Glucose, even with the addition of
5 uM Oligomycin A. ECAR levels decreased upon 20 mM 2-DG
treatment. (C) An increase in OCR levels in HIF1dPA+ shPdk1 cells
was observed following Glucose treatment. OCR levels fell with the
addition of 5 uM Oligomycin A and following 2 uM Antimycin A and
2 uM Rotenone co-treatment. Lines indicate average with the SEM. ‘p#
0.001.
doi:10.1371/journal.pone.0098705.g005
Figure 6. HIF2 glutamine utilization is deterred by Glul
expression. (A) Glul knockdown by siRNA in HIF2dPA+ cells was
,15% compared to untreated cells as confirmed by qRT-PCR. (B)
Knockdown of Glul in HIF2dPA+ cells in 2 mM L-glutamine-supple-
mented media showed an increase in OCR over HIF2dPA+ cells. OCR
levels decreased following 2 uM Antimycin A and 2 uM Rotenone co-
treatment. Lines indicate average with the SEM. *p#0.05.
doi:10.1371/journal.pone.0098705.g006
HIF1 and HIF2 Effects on Metabolic Programs
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epithelial cells, substrate availability for the TCA cycle is regulated
by at least two nutrient pathway-specific points, pyruvate derived
from glucose utilization and glycolysis, and glutamate derived from
glutamine. HIF1 preferentially drives glucose metabolism, but can
support the TCA cycle and oxidative phosphorylation when
nutrient sources are unlimited, likely through both glutamine
uptake and conversion to glutamate, as well as pyruvate
conversion to acetyl coA. However, when nutrients are limited,
glucose is preferentially utilized for glycolysis and the produced
pyruvate is primarily shuttled into lactic acid production, as a
result HIF1 is unable to support oxidative phosphorylation as
nutrients become limiting. HIF2, in contrast, has minimal
influences on glycolysis, but effectively supports oxygen consump-
tion in nutrient rich environments, using primarily glucose, but not
glutamine as a carbon source for substrate production. The
limitation on glutamine utilization is at least partly driven by
transcriptional upregulation of Glul, resulting in the shuttling of
glutamate away from the TCA cycle. Knockdown of Glul releases
this blockade, and permits highly effective oxidative phosphory-
lation using glutamine as a carbon source.
Conclusions
Utilizing an endogenous HIF1 and HIF2 stable expression
system in primary kidney cells, we were able to show that these
related transcription factors have very different roles in the
regulation of essential metabolic pathways. HIF1 has a greater role
in regulating expression of key glycolytic enzymes and this effect is
observed as an increase in glucose consumption and glycolytic
acidification, but in nutrient rich conditions, HIF1 can support
increased oxidative phosphorylation using a variety of TCA
substrates. In contrast, HIF2 expression selectively increased
oxygen consumption, and favored nutrient utilization of glucose.
This preference appears to be due to a selective shuttling of TCA
substrate glutamate back to glutamine, effectively limiting the
ability of these cells to utilize glutamine as a carbon for energy
production. The advantage of this blockade to cells is not clear.
However, these findings suggest that HIF1 and HIF2 have
preferential influences on metabolic activities, but that these
energetic processes are dynamic and highly dependent on nutrient
availability.
Materials and Methods
Ethics Statement
All animal work was done in accordance with the University of
North Carolina at Chapel Hill Division of Laboratory Animal
Medicine and was approved by the University of North Carolina
at Chapel Hill Institutional Animal Care and Use Committee.
(Protocol #12–195).
Primary Cell Isolation and Culture
Transgenic mice containing human UBC-CreER
T2 allele (Stock
#008085) were purchased from JAX laboratories [9]. R26-LSL,
HIFdPA mice were generously provided by Dr. William Y. Kim
[25]. Animals were maintained on a standard chow. Adapted from
previously published protocols [26,27], bilateral kidneys were
harvested from neonatal mice one to three days after birth. Both
kidneys were rinsed in Dulbecco’s Phosphate Buffered Saline (D-
PBS) twice. Tissues were crushed using plastic pestles and
dissociated in 1 mg/mL Collagenase IV (Worthington) at 37uC
for 40 minutes with intermediate vortexing. Cell/tissue suspension
was washed in DMEM/F12 (Gibco) media twice to separate, by
gravity, large remaining tissue pieces from cell suspension. The
remaining cell suspension was washed in DMEM/F12 media and
centrifuged at 500 rpm several times. Cells were cultured in NEK
media at 37uC, 5%CO2. Cells were immortalized by treatment
with 6 ug/mL polybrene in filtered conditioned media from
y2SV40 cell culture, for 48 hours. The cells were subsequently
cultured as an immortalized cell line. Cell cultures were
recombined using NEK media containing 1610
6 units/mL
Adenovirus Cre (University of Iowa, vector lab) for 48 hrs (for
initial recombination) or 0.1 mM Z-4-hydroxytamoxifen (4-OHT)
(Sigma) for 72 hours.
Cells were cultured in NEK media: DMEM/F12 base media,
Insulin Transferrin Selenium (Gibco), Penicillin/Streptomycin
(Gibco), 12 ng/mL human Epidermal Growth Factor (Sigma,
Gemini Bioproducts).
Cell Genotyping
Genomic DNA was extracted from cell suspension, by
incubating a small cell pellet with 20 mg/mL Proteinase K
solution at 55uC for 3 hours followed by 95uC for 15 mins. gDNA
was then used to genotype each sample for the R26-LSL
recombinant allele by polymerase chain reaction (PCR). PCR
product was run on a 3% TAE agarose gel.
Quantitative Real Time Polymerase Chain Reaction
cDNA was generated using SuperScript II Reverse Transcrip-
tase (Invitrogen). qRT-PCR was performed using primer pairs
designed using the online IDT Realtime PCR Scitools; primer
sequences available upon request. The Maxima SYBR Green/
Rox qPCR Master Mix (Thermo Scientific) and protocol were
used for qRT-PCR. Samples were run on an Applied Biosystems
Real-Time PCR Instrument. Sample cycle thresholds were
normalized to Beta Actin. Fold change was calculated to the
corresponding unrecombined cell line. Average fold change and
standard error of the mean were graphed; Student’s two-tailed T-
Test was performed to calculate significance at p#0.05, p#0.01,
or p#0.001.
Quantitative Infrared Western Blot
Nuclear extractions of cells were conducted using the NE-PER
Nuclear/Cytoplasmic Extraction Kit protocol (Pierce). ,50 ug of
protein from the nuclear extracts were run on a SDS-PAGE gel,
transferred onto nitrocellulose membranes at 4uC, and washed in
PBS-T. The membranes were blocked in 5% BSA in PBS,
followed by incubation in 1:1000 Rb anti-HIF-1a (Novus)/
1:500 Gt anti-Lamin B (Santa Cruz) solution in 5% BSA in PBS
overnight at 4uC. The membranes were incubated in 1:10,000
anti-Rb and anti-Gt secondary antibody at two different infrared
channels in 5% BSA in PBS. The membranes were visualized on
an Odyssey classic instrument; quantification of band intensity was
done using Odyssey LI-COR software. Fold change of infrared
fluorescence readings was done for HIF1 over nuclear Lamin B.
Immunocytochemistry
200 uL of a 5610
5 cell suspension was used to cyto-spin cells
onto a glass slide. The attached cells air-dried and were fixed in
3% Paraformaldehyde and permeabilized in a 0.25% Triton-
X100 in PBS solution. Endogenous peroxidase activity was
blocked by incubation in a 1% H2O2 solution. The samples were
blocked in 5% BSA in PBS, then incubated in 1:200 Rb anti-HIF-
2a (Novus) primary antibody overnight in a humidified chamber.
Secondary anti-rabbit antibody was added at 1:10,000. Horse-
radish peroxidase (HRP) conjugation of the antigen in ABC-HRP
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substrate solution (Vector Kit). Slides were counterstained with
hematoxylin, dehydrated and coverslip mounted. Images were
captured using an Olympus CX41 microscope with a mounted
Infinity2 camera and Image Capture software. Stain intensity of
individual cells was quantified using Image J software [43]. The
average corrected total cell staining was graphed with standard
error of the mean; Student’s two-tailed T-Test was performed to
calculate significance at p#0.01.
Seahorse Metabolic Assay
Metabolic activity was measured using the Seahorse Biosciences
XF24 Extracellular Flux Analyzer (Seahorse Biosciences) was used
according to previously published methods [35]. 24-well Seahorse
assay plate was coated with Cell-Tak (BD) to immobilize the cells.
4.5610
4 cells were plated in 24 well Seahorse assay plate (in
replicates of 3–5), with triplicate blank wells to correct for the
background. Cells were allowed to adhere at 37uC, 5% CO2.A t
the start of the experiment, the plated cells are washed in XF
media with 10 mM Glucose added for complete nutrient media
treatment. The sensor plate was hydrated overnight in XF
calibrant media at 37uC and no-CO2, prior to calibration it was
loaded with the indicated inhibitors or nutrients for a ten-fold
dilution in the XF assay. Final concentrations used were 10 mM
or 20 mM 2-deoxy-D-glucose (Sigma), 750 nM or 2 uM Rote-
none (Ultra Scientific), 2 uM Antimycin A (Fisher Scientific),
10 mM Glucose (Fisher Scientific), 5 uM Oligomycin A (Fisher
Scientific). Average fold change and standard error of the mean
were graphed; Student’s two-tailed T-Test was performed to
calculate significance at p#0.05, p#0.01, or p#0.001.
XF assays with carbon-limited media were run using DME base
media (D5030, Sigma, powder) dissolved in double processed
water (W3500, Sigma) and brought to final concentration of
143 mM NaCl, Penicillin/Streptomycin (Gibco), with pH 7.1–7.3.
For each limited carbon assay, the DME base media was brought
to a final concentration of 10 mM Glucose (Fisher Scientific) or
2 mM L-glutamine (Gibco).
Knockdown Assays
Cells were plate on XF cell culture plates, as described above, in
NEK media without antibiotic (NEK-P/S) and allowed to adhere
for three hours at 37uC, 5%CO2. Pooled shPdk1 lentiviruses
(Sigma) were used and a shEmptyVector lentivirus was used as a
negative control. shRNAs in NEK-P/S media were placed on the
attached cell cultures treated with polybrene. Pooled siRNAs
(siGlul, siNS, siGAPD) (Thermo Scientific) were reconstituted to
5 uM concentration in ddH2O. siRNAs were prepared for
transfection using the DharmaFECT transfection reagent accord-
ing to the manufacturer’s protocol (Thermo Scientific). Cells were
incubated with siRNA for 24 hours at 37uC, 5% CO2. Seahorse
metabolic assay on knockdown cells was performed as previously
described 24 hours post-transfection. Separate cells were treated
for RNA extractions at 24 hours post-transfection, to confirm
knockdown efficiency by qRT-PCR.
Glycolytic Flux
This assay was performed as previously published [44]. Glucose
flux was determined in 2610
6 viable cells by washing in PBS
followed by incubation in glucose-free Kreb’s buffer for 30 min
prior to addition of 10 mCi of D-[5-
3H](N)-glucose (PerkinElmer,
Wellesley, MA) and non–radio-labeled glucose to bring total
glucose concentration to 10 mM prior to culture for 1 hour.
Reactions were stopped by addition of an equal volume of 0.2 N
HCl. [
3H]H20 was separated from [
3H]glucose by evaporated
equilibrium in a sealed environment. Levels of [
3H]H20 produced
were measured on a scintillation counter, and glycolytic flux was
calculated as described [44]. Average fold change and standard
error of the mean were graphed; Student’s two-tailed T-Test was
performed to calculate significance at p#0.05, p#0.01, or p#
0.001.
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